rhodamine 110 has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, S; Dobrolecki, LE; Ge, G; Kaffes, CC; Lewis, MT; Mukherjee, M; Pati, D; Scorsone, K; Stephan, CC; Zhang, N | 1 |
1 other study(ies) available for rhodamine 110 and Breast Cancer
Article | Year |
---|---|
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy.
Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Damage; DNA-Binding Proteins; Female; High-Throughput Screening Assays; Humans; Hydrolysis; Inhibitory Concentration 50; Maximum Tolerated Dose; Mice; Microscopy, Fluorescence; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Peptides; Phosphoproteins; Rhodamines; Separase | 2014 |